Stanciakova L, Skerenova M, Holly P, Dobrotova M, Ivankova J, Stasko J, Kubisz P

Language: English
References: 21
Page: 139-143
PDF size: 384.13 Kb.

ABSTRACT

The sticky platelet syndrome (SPS) is a prothrombotic platelet disorder, associated with increased platelet aggregability with both adenosine diphosphate (ADP) and epinephrine (EPI). Type I of the disorder is the most common phenotype in Mexican mestizos and SPS is even reported to be the second most common hereditary thrombophilic state in this particular population. It accounts for 48% of all thrombophilic disorders diagnosed in patients with unprovoked thromboembolic events. SPS is detected in patients with arterial and venous thrombotic episodes, and these can even be present concomitantly in one person or his/her relatives. The syndrome contributes more often to arterial than to venous thrombosis (21% of unexplained arterial thrombotic events vs 13% of otherwise unexplained venous thromboembolic episodes). SPS is also the most frequent thrombophilia contributing to arterial thrombotic events and possibly the leading cause of thrombosis in the atypical parts of the circulation. Several families with SPS have been described; the affected members of one family may not express the same SPS type and there are even the cases of the negativity of their family history. Various mutations of one or more genes contribute to similar SPS phenotype. Additionally, platelets of the patients with atherosclerosis, autoimmune and renal diseases showed hyperaggregability after the addition of EPI or other agonists, pointing to the possible acquired forms of SPS. Moreover, the diagnosis of SPS is based on clinical manifestation and laboratory parameters, not on the results of genetic analysis. Therefore, currently we cannot state that SPS is inherited exactly in autosomal dominant trait, as it was originally proposed.

REFERENCES

1. Mammen EF. Sticky platelet syndrome. Semin Thromb Hemost 1999;25:361-365.

2. Kubisz P, Ruiz-Argüelles GJ, Stasko J, Holly P, Ruiz-Delgado GJ. Sticky platelet syndrome: history and future perspectives. Semin Thromb Hemost. 2014;40:526-34. DOI: 10.1055/s-0034-1381235.

3. Kubisz P, Stanciakova L, Stasko J, et al. Sticky platelet syndrome: an important cause of life-threatening thrombotic complications. Expert Rev Hematol. 2016;9:21-35. DOI: 10.1586/17474086.2016.1121095.

4. Ruiz-Argüelles GJ, López-Martínez B, Cruz-Cruz D, Esparza- Silva L, Reyes-Aulis MB. Primary thrombophilia in Mexico III: a prospective study of the sticky platelet syndrome. Clin Appl Thromb Hemost 2002;8:273-277.

5. Ruiz-Argüelles GJ, López-Martínez B, Valdés-Tapia P, Gómez-Rangel JD, et al. Primary thrombophilia in Mexico. V. A comprehensive prospective study indicates that most cases are multifactorial. Am J Hematol 2005;78:21-26.

6. Ruiz-Argüelles GJ, Ruiz-Delgado GJ. Trombofilia. In: Ruiz- Argüelles GJ, Ruiz-Delgado GJ, editores. Fundamentos de Hematología. 5a ed. Ciudad de México: Editorial Médicsa Panamericana, 2014;287-296.

7. Kubisz P, Stasko J, Holly P. Sticky platelet syndrome. Semin Thromb Hemost. 2013;39:674-683. DOI: 10.1055/s-0033- 1353394.

8. Bick RL. Sticky platelet syndrome: a common cause of unexplained arterial and venous thrombosis. Clin Appl Thromb/Hemost 1998;4:77-81.

9. Ruiz-Argüelles GJ, González-Carrillo ML, Estrada-Gómez R, Valdés-Tapia P, et al. Primary thrombophilia in México. VI: lack of statistical association among the inherited thrombophilic conditions. Gac Méd Méx 2007;143:317- 322.

10. Michelson AD, Furman MI, Goldschmidt-Clermont P, et al. Platelet GP IIIa Pl(A) polymorphisms display different sensitivities to agonists. Circulation 2000;101:1013101-8.

11. Feng D, Lindpaintner K, Larson MG, et al. Increased platelet aggregability associated with platelet GPIIIa PlA2 polymorphism: The Framingham Offspring Study. Arterioscler Thromb Vasc Biol 1999;19:1142-1147.

12. Kubisz P, Ivankov J, Holly P, Stasko JN, Musiał J. The glycoprotein IIIa PL(A1/A2) polymorphism--a defect responsible for the sticky platelet syndrome? Clin Appl Thromb Hemost 2006;12:117-119.

13. Ruiz-Argüelles GJ, Garcés-Eisele J, Camacho-Alarcón C, et al. Primary thrombophilia in Mexico IX: the glycoprotein IIIa PLA1/A2 polymorphism is not associated with the sticky platelet syndrome phenotype. Clin Appl Thromb Hemost 2013;19:689-692. DOI: 10.1177/1076029612448418.

14. Muñoz X, Obach V, Hurtado B, de Frutos PG, et al. Association of specific haplotypes of GAS6 gene with stroke. Thromb Haemost 2007;98:406-412.

15. Sokol J, Biringer K, Skerenova M, Stasko J, et al. Different models of inheritance in selected genes in patients with sticky platelet syndrome and fetal loss. Semin Thromb Hemost 2015;41:330-335. DOI: 10.1055/s-0034-1395351.

16. Jung SM, Moroi M. Platelet glycoprotein VI. Adv Exp Med Biol 2008;640:53-63. DOI: 10.1007/978-0-387-09789-3_5.

17. Kubisz P, Ivanková J, Škereňová M, Staško J, Hollý P. The prevalence of the platelet glycoprotein VI polymorphisms in patients with sticky platelet syndrome and ischemic stroke. Hematology. 2012;17:355-362. DOI: 10.1179/102 4533212Z.000000000142.

18. Kotuličová D, Chudý P, Škereňová M, Ivanková J, et al. Variability of GP6 gene in patients with sticky platelet syndrome and deep venous thrombosis and/or pulmonary embolism. Blood Coagul Fibrinolysis 2012;23:543-547. DOI: 10.1097/MBC.0b013e328355a808.

19. Sokol J, Biringer K, Skerenova M, et al. Platelet aggregation abnormalities in patients with fetal losses: the GP6 gene polymorphism. Fertil Steril 2012;98:1170-1174. DOI: 10.1016/j.fertnstert.2012.07.1108.

20. Sokol J, Skerenova M, Biringer K, Lasabova Z, et al. Genetic variations of the GP6 regulatory region in patients with sticky platelet syndrome and miscarriage. Expert Rev Hematol 2015;8:863-868. DOI: 10.1586/17474086.2015.1083417.

21. Kauskot A, Di Michele M, Loyen S, Freson K, et al. A novel mechanism of sustained platelet αIIbβ3 activation via PEAR1. Blood. 2012;119:4056-4065. DOI: 10.1182/ blood-2011-11-392787.